Hirve, Siddhivinayak <br/><br/>
Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.  [electronic resource] 

 -  Vaccine  Oct 2012 
 - 6456-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2012.08.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Bacterial--blood<br/>Child<br/>Child, Preschool<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunoglobulin G--blood<br/>India<br/>Male<br/>Meningitis, Meningococcal--prevention & control<br/>Meningococcal Vaccines--administration & dosage<br/>Polysaccharides, Bacterial--administration & dosage<br/>Serum Bactericidal Antibody Assay<br/>Vaccines, Conjugate--administration & dosage